These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 28160548

  • 1. Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer.
    Bhardwaj A, Singh H, Rajapakshe K, Tachibana K, Ganesan N, Pan Y, Gunaratne PH, Coarfa C, Bedrosian I.
    Oncotarget; 2017 Mar 21; 8(12):19645-19660. PubMed ID: 28160548
    [Abstract] [Full Text] [Related]

  • 2. The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer.
    Bhardwaj A, Singh H, Trinidad CM, Albarracin CT, Hunt KK, Bedrosian I.
    Breast Cancer Res; 2018 Dec 11; 20(1):150. PubMed ID: 30537987
    [Abstract] [Full Text] [Related]

  • 3. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M, Li AQ, Zhou SL, Lv H, Wei P, Yang WT.
    J Exp Clin Cancer Res; 2020 May 24; 39(1):92. PubMed ID: 32448269
    [Abstract] [Full Text] [Related]

  • 4. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
    Chen H, Pan H, Qian Y, Zhou W, Liu X.
    Mol Cancer; 2018 Jan 08; 17(1):4. PubMed ID: 29310680
    [Abstract] [Full Text] [Related]

  • 5. CPNE1 predicts poor prognosis and promotes tumorigenesis and radioresistance via the AKT singling pathway in triple-negative breast cancer.
    Shao Z, Ma X, Zhang Y, Sun Y, Lv W, He K, Xia R, Wang P, Gao X.
    Mol Carcinog; 2020 May 08; 59(5):533-544. PubMed ID: 32181526
    [Abstract] [Full Text] [Related]

  • 6. Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer.
    Kim YJ, Sung M, Oh E, Vrancken MV, Song JY, Jung K, Choi YL.
    Cancer Biol Ther; 2018 Apr 03; 19(4):335-345. PubMed ID: 29333926
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z, Meng Q, Pan A, Wu X, Cui J, Wang Y, Li L.
    Oncotarget; 2017 Mar 21; 8(12):19455-19466. PubMed ID: 28038450
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S, Zhou J, Wang Z, Wang P, Gao X, Wang Y.
    Biomed Pharmacother; 2018 Aug 21; 104():451-457. PubMed ID: 29793177
    [Abstract] [Full Text] [Related]

  • 12. Circ-TFCP2L1 Promotes the Proliferation and Migration of Triple Negative Breast Cancer through Sponging miR-7 by Inhibiting PAK1.
    Wang Q, Li Z, Hu Y, Zheng W, Tang W, Zhai C, Gu Z, Tao J, Wang H.
    J Mammary Gland Biol Neoplasia; 2019 Dec 21; 24(4):323-331. PubMed ID: 31776835
    [Abstract] [Full Text] [Related]

  • 13. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease.
    Qattan A.
    Int J Mol Sci; 2020 Nov 24; 21(23):. PubMed ID: 33255471
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer.
    Wu J, Sun Z, Sun H, Li Y.
    Mol Med Rep; 2018 Jan 24; 17(1):562-570. PubMed ID: 29115608
    [Abstract] [Full Text] [Related]

  • 15. Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression.
    Guo B, Wu S, Zhu X, Zhang L, Deng J, Li F, Wang Y, Zhang S, Wu R, Lu J, Zhou Y.
    EMBO J; 2020 Jan 02; 39(1):e102190. PubMed ID: 31755573
    [Abstract] [Full Text] [Related]

  • 16. MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib.
    Jonas K, Prinz F, Ferracin M, Krajina K, Pasculli B, Deutsch A, Madl T, Rinner B, Slaby O, Klec C, Pichler M.
    Breast Cancer Res; 2023 Oct 06; 25(1):119. PubMed ID: 37803350
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of PRMT1 in EGFR methylation and signaling in MDA-MB-468 triple-negative breast cancer cells.
    Nakai K, Xia W, Liao HW, Saito M, Hung MC, Yamaguchi H.
    Breast Cancer; 2018 Jan 06; 25(1):74-80. PubMed ID: 28643125
    [Abstract] [Full Text] [Related]

  • 19. Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics.
    Ou-Yang F, Pan MR, Chang SJ, Wu CC, Fang SY, Li CL, Hou MF, Luo CW.
    Life Sci; 2019 Dec 01; 238():116963. PubMed ID: 31639396
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.